Blog

Gilead Sciences, a major pharmaceutical company, recently unveiled a major initiative to fight HIV globally by enabling the production of a generic version of its breakthrough drug, lenacapavir. This injectable drug, administered every two years, has demonstrated exceptional effectiveness in preventing HIV infections. Under the new agreement, Gilead will grant free licenses to six generic drug makers based in Asia and North Africa. These manufacturers are authorized to distribute the drug at a reduced cost in 120 countries, mostly in sub-Saharan Africa, the regions most affected by HIV. This strategic move aims to make this life-saving treatment accessible to those…

As marijuana legalization expands in the United States, concerns about potential health risks are growing. While most users have no problems, a growing number, particularly heavy users, report addiction, psychosis and other negative consequences. Dr. Kevin Gray, a psychiatrist specializing in bio-behavioral medicine, highlights the complex nature of cannabis: “Cannabis has both therapeutic and potentially problematic effects.” The New York Times interviewed hundreds of people experiencing serious and sometimes frightening symptoms related to cannabis use. One story tells of actor David Krumholtz, who after resuming marijuana use, developed cannabinoid hyperemesis syndrome (CHS). This debilitating condition causes cycles of intense nausea…